SAVA
Cassava Sciences Inc
-13.96%
$29.88 - $25.71
Feb 7th 2023 - Mar 21st 2023
Mar, 21, 2023
$CDTX FDA decision will be made tomorrow $SAVA, $M... See more
Jan, 11, 2023
$SAVA I'm loving the move, can't wait for ... See more
NIO
NIO Inc - ADR
-15.11%
$10.92 - $9.27
Feb 7th 2023 - Mar 21st 2023
Feb, 6, 2023
$TMC nice 23% in a day and this will continue for ... See more
Dec, 15, 2022
$COIN $SPY $NIO Bearish approval š©øš°
SHCR
Sharecare Inc - Ordinary Shares - Class A
-13.91%
$2.66 - $2.29
Feb 7th 2023 - Mar 21st 2023
Mar, 21, 2023
$CDTX FDA decision will be made tomorrow $SAVA, $MDGL & $RETA boys I can easily see this up 200%-300% in my opinion on an approval.
Jan, 11, 2023
$SAVA I'm loving the move, can't wait for the approval, buy out at $500, sell at $1200.
Jan, 7, 2023
$SAVA diseases like Alzheimerās will have more Than 1 drug approved for the indication.. being first is great,
Jan, 6, 2023
$SAVA FDA approved Biogen's AD drug is bullish for SAVA.
Jan, 6, 2023
$SAVA biib up 3.00 on approval sava will go up 100+ on approval
Jan, 6, 2023
no more speculation, now it's real, two FDA approved meds, two major products, top of the line in comparison of their rivals, for cheaper price, AND WITH NO MUCH COMPETITION!
Jan, 6, 2023
$SAVA When FDA approved Aduhelm (aducanumab), which was a failure, on June 7 2021, SAVA was up 33% within a day following that news! !
Nov, 6, 2022
This formula has already proved to be effective, and if FDA approved can potentially be sold for billions.
Oct, 20, 2022
This share price is a steal with those great Levo results this morning, and their other 3 approved and growing products.
Oct, 14, 2022
Simufilam boosts soluble level of Amyloid bera42 which in turn improves or maintains cognition in Alz patients This, along with its superior safety profile, will win the approval undoubtedly!
Feb, 6, 2023
$TMC nice 23% in a day and this will continue for the next 6 months until permits are approved.
Dec, 15, 2022
$COIN $SPY $NIO Bearish approval š©øš°
Nov, 18, 2022
We are about to enter a rally my friends šš¼covid lockdowns easing, SEC audit approval within 30 days, 45k deliveries in Q4.
Nov, 7, 2022
With no adverse side affects approval is deemed appropriate.
Nov, 7, 2022
With no adverse side affects approval is deemed appropriate.
Nov, 6, 2022
This formula has already proved to be effective, and if FDA approved can potentially be sold for billions.
Nov, 6, 2022
This formula has already proved to be effective, and if FDA approved can potentially be sold for billions.
Nov, 1, 2022
With no adverse side affects approval is deemed appropriate.
Oct, 31, 2022
With no adverse side affects approval is deemed appropriate.
Oct, 29, 2022
With no adverse side affects approval is deemed appropriate